Gumley Andrew, Karatzias Athanasios, Power Kevin, Reilly James, McNay Lisa, O'Grady Margaret
University of Glasgow, UK.
Br J Clin Psychol. 2006 Jun;45(Pt 2):247-60. doi: 10.1348/014466505X49925.
The study aimed to test two hypotheses. Firstly, that participants who relapsed during the 12-month follow-up period of our randomized controlled trial, would show increased negative beliefs about their illness and reduced self-esteem, in comparison to the non-relapsed participants. Secondly, that cognitive behavioural therapy (CBT) for early signs of relapse would result in a reduction in negative beliefs about psychosis and an improvement in self-esteem at 12 months.
A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU; N=72) or CBT (N=72). Participants completed the Personal Beliefs about Illness Questionnaire (PBIQ; Birchwood, Mason, MacMillan, & Healy, 1993) and the Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965) at entry, 3 months, 6 months, and 12 months.
At 12 months, relapsers showed greater increase in scores for PBIQ entrapment compared with non-relapsers. In addition, after controlling for baseline covariates (treatment group and PBIQ self versus illness), relapsers also showed greater increase in scores for PBIQ self versus illness at 12 months. Furthermore, in comparison to treatment as usual, participants who received CBT showed greater improvement in PBIQ loss and in Rosenberg self-esteem.
The study provides evidence that relapse is associated with the development of negative appraisals of entrapment and self-blame (self vs. illness). In addition, this is the first study to show that CBT reduces negative appraisals of loss arising from psychosis and improvements in self-esteem. Implications for future research and treatment are discussed.
本研究旨在验证两个假设。其一,在我们的随机对照试验12个月随访期内复发的参与者,与未复发的参与者相比,对自身疾病的消极信念会增加,自尊会降低。其二,针对复发早期迹象的认知行为疗法(CBT)将导致在12个月时对精神病的消极信念减少,自尊得到改善。
总共144名患有精神分裂症或相关障碍的参与者被随机分为接受常规治疗(TAU;N = 72)或CBT(N = 72)。参与者在入组时、3个月、6个月和12个月时完成了关于疾病的个人信念问卷(PBIQ;Birchwood、Mason、MacMillan和Healy,1993)以及罗森伯格自尊量表(RSES;Rosenberg,1965)。
在12个月时,复发者在PBIQ受困得分上的增加幅度大于未复发者。此外,在控制了基线协变量(治疗组以及PBIQ自我与疾病得分)后,复发者在12个月时PBIQ自我与疾病得分的增加幅度也更大。此外,与常规治疗相比,接受CBT的参与者在PBIQ丧失得分和罗森伯格自尊方面有更大改善。
该研究提供了证据表明复发与对受困和自责(自我与疾病)的消极评价的发展有关。此外,这是第一项表明CBT可减少因精神病产生的丧失的消极评价并改善自尊的研究。讨论了对未来研究和治疗的启示。